- Home
- / Services
- / Monoclonal Antibody Generation
- / Hybridoma Development
- / Rodent Models
Monoclonal Antibody Generation
Hybridoma Development - Rodent Models
Rodent Models
Overview
LAMPIRE offers hybridoma development services across multiple species, including mouse, hamster, and rat, allowing for flexibility in targeting a wide range of antigens. Each species provides unique immunological advantages, enabling us to tailor antibody generation strategies to meet specific project goals.
By leveraging species-specific strengths, we help maximize immune response, improve antibody specificity, and enhance overall project success.
Why Choose Us?
Species Flexibility
Access to mouse, hamster, and rat models
Tailored Immunization Strategies
Selection of the optimal host based on antigen and project goals
Proven Hybridoma Expertise
Decades of experience in monoclonal antibody development
Robust Infrastructure
Established capabilities in animal care, immunization, and hybridoma production
US based, AAALAC accredited facilities with quality oversight
Mouse Hybridoma Development
- Strong and reliable immune response across a wide range of antigens
- Extensive availability of inbred, outbred, and transgenic strains
- Ideal for targeting conserved or human proteins
- Well-characterized genetics supporting reproducibility and experimental design
- Widely accepted model for therapeutic and diagnostic antibody development
Hamster Hybridoma Development
- Evolutionary distance from mice reduces cross-reactivity with murine antigens
- Improved specificity and reduced background in mouse-targeted applications
- Availability of Syrian and Armenian hamster strains for project customization
- Well-characterized genExcellent stability of monoclonal antibody production over timeetics supporting reproducibility and experimental design
- Ideal for generating antibodies against mouse proteins or closely related targets
Rat Hybridoma Development
- Enhanced immune responses, particularly against mouse immunogens
- Higher lymphocyte yield, increasing hybridoma generation efficiency
- Broader and more diverse antibody repertoire
- Reduced immune tolerance for difficult or weakly immunogenic targets
- Valuable for epitope mapping and cross-reactivity studies
Applications
- Therapeutic antibody discovery and development
- Diagnostic assay development
- Biomarker detection and validation
- Research reagent generation
- Antibody generation against challenging or highly conserved targets
CONTACT US
Schedule a Free Consultation
"*" indicates required fields